Sanofi India Limited (BOM: 500674)
India flag India · Delayed Price · Currency is INR
6,175.85
+75.15 (1.23%)
At close: Dec 20, 2024

Sanofi India Company Description

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012.

The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Sanofi India Limited
Country India
Founded 1956
Industry Pharmaceutical Preparations
Employees 2,174
CEO Rodolfo Hrosz

Contact Details

Address:
Sanofi House
Mumbai, 400072
India
Phone 91 22 2803 2000
Website sanofiindialtd.com

Stock Details

Ticker Symbol 500674
Exchange Bombay Stock Exchange
Fiscal Year January - December
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Rodolfo Hrosz Chief Executive Officer
Rachid Ayari Chief Financial Officer